GlobeStar Therapeutics Corp
General ticker "GSTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $362.7K
GlobeStar Therapeutics Corp does not follow the US Stock Market performance with the rate: -32.1%.
Estimated limits based on current volatility of 17.7%: low 0.00$, high 0.00$
Factors to consider:
- Current price 67.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [0.00$, 0.00$]
- 2024-09-29 to 2025-09-29 estimated range: [0.00$, 0.00$]
Financial Metrics affecting the GSTC estimates:
- Negative: Non-GAAP EPS, $ of 0 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -8.87 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -24.49 <= 3.85
- Negative: Industry earnings per price (median), % of -26.09 <= 1.31
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term GSTC quotes
Long-term GSTC plot with estimates
Financial data
| YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $9.09MM | $1.27MM | $1.86MM |
| Operating Income | $-9.09MM | $-1.27MM | $-1.86MM |
| Non-Operating Income | $-0.71MM | $-0.21MM | $-0.08MM |
| Interest Expense | $0.29MM | $0.07MM | $0.09MM |
| Income(Loss) | $-9.80MM | $-1.48MM | $-1.95MM |
| Profit(Loss) | $-9.80MM | $-1.48MM | $-1.95MM |
| Stockholders Equity | $-0.73MM | $-1.19MM | $-1.43MM |
| Assets | $0.01MM | $0.01MM | $0.00MM |
| Operating Cash Flow | $-0.75MM | $-0.33MM | $-0.21MM |
| Financing Cash Flow | $0.68MM | $0.33MM | $0.20MM |
| Earnings Per Share* | $-0.02 | $-0.00 | $-0.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.